Code	Sector	Market
504A	Pharmaceuticals	Growth

Date of listing approval	2026/01/19
Expected Date	2026/02/24
Lead Underwriter	Nomura Securities Co., Ltd
Description

Listed Shares(total)	9,125,300
Trading Unit	100
New Shares	8,400,000
Existing Shares	725,300
Shares Outstanding	PreIPO 33,335,702.00
	PostIPO 41,735,702.00
Paid Up Capital	PreIPO Y4,131,360,000
	PostIPO
Expected Pricing Date	2026/02/04
Book Building Start	2026/02/05
Book Building End	2026/02/10
Fix Date	2026/02/12
Offering Starts	2026/02/13
Offering Ends	2026/02/18
Expect Pricing	-
Notional PER (based on previous period)	-
Offering Price
Offering Price PER (based on previous period)	-
Offering Price PBR (based on previous period)
Use of Funds Raised

Units:Y1,000

Fiscal Year End:2022/12
	Consolidated	Non-consolidated
Revenue	-	-
Current Profit	-	-514,321
Net Profit	-	-515,271
Net Assets	-	1,811,061

Fiscal Year End:2023/12
	Consolidated	Non-consolidated
Revenue	-	-
Current Profit	-2,000,857	-515,539
Net Profit	-2,002,340	-516,489
Net Assets	-1,737,916	2,129,572

Fiscal Year End:2024/12
	Consolidated	Non-consolidated
Revenue	-	-
Current Profit	-2,391,551	-771,949
Net Profit	-2,392,439	-772,899
Net Assets	-1,956,100	3,637,134

Recent Quarter 2025/09
	Consolidated	Non-consolidated
Revenue	-	-
Current Profit	-2,093,627	-
Net Profit	-2,094,596	-
Net Assets	316,149	-

Per Share Units:Y1

Fiscal Year End:2022/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-	-
Equity	-20.64	68.13

Fiscal Year End:2023/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-75.39	-96.94
Equity	-19.45	48.68

Fiscal Year End:2024/12
	Consolidated	Non-consolidated
Dividend	0.00
Net Earning	-89.42	-64.57
Equity	-28.89	119.89

■Over allotment (1,368,700)

Name	Address

Allocation	Underwriter	Tel
0%	Nomura	03-3211-1811
0%	Nomura Securities Co., Ltd	03-3211-1811
0%	SBI SECURITIES Co.,Ltd.	03-5562-7210